| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.379 | 1.071 | 23.715 | 22.589 | 26.980 | 26.294 | 34.670 | 33.837 | 31.505 | 39.029 |
| Total Income - EUR | 1.379 | 1.071 | 25.672 | 27.371 | 60.443 | 64.553 | 50.002 | 47.873 | 47.352 | 38.066 |
| Total Expenses - EUR | 1.184 | 7.754 | 32.033 | 36.641 | 43.305 | 38.358 | 38.218 | 38.684 | 42.220 | 45.180 |
| Gross Profit/Loss - EUR | 195 | -6.683 | -6.361 | -9.270 | 17.138 | 26.195 | 11.783 | 9.189 | 5.133 | -7.113 |
| Net Profit/Loss - EUR | 154 | -6.715 | -6.612 | -9.498 | 16.537 | 25.740 | 11.397 | 8.786 | 4.713 | -7.465 |
| Employees | 0 | 0 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Medovemi Prest S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 186 | 236 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 10.211 | 3.350 | 14.487 | 16.189 | 13.688 | 14.690 | 23.783 | 30.268 | 35.367 | 28.273 |
| Inventories | 6.016 | 1.002 | 12.079 | 13.721 | 11.684 | 13.621 | 22.757 | 28.926 | 33.349 | 24.837 |
| Receivables | 2.156 | 12 | 2.302 | 2.328 | 1.340 | 649 | 739 | 433 | 432 | 2.200 |
| Cash | 2.039 | 2.335 | 106 | 139 | 664 | 420 | 288 | 909 | 1.585 | 1.236 |
| Shareholders Funds | -12.425 | -19.013 | -25.304 | -34.337 | -17.134 | 8.931 | 20.129 | 28.978 | 33.603 | 25.950 |
| Social Capital | 85 | 85 | 83 | 82 | 80 | 79 | 77 | 77 | 77 | 76 |
| Debts | 22.636 | 22.363 | 39.791 | 50.712 | 31.058 | 5.759 | 3.654 | 1.291 | 1.763 | 2.323 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3109 - 3109" | |||||||||
| CAEN Financial Year |
3109
|
|||||||||
Comments - Medovemi Prest S.r.l.